πŸ‡ΊπŸ‡Έ FDA
Patent

US 11058729

Exosomes and miRNA to treat glaucoma

granted A61KA61K31/4178A61K31/498

Quick answer

US patent 11058729 (Exosomes and miRNA to treat glaucoma) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jul 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/4178, A61K31/498, A61K31/5377, A61K31/5575